Neostigmine Methylsulfate
These highlights do not include all the information needed to use NEOSTIGMINE METHYLSULFATE INJECTION safely and effectively.See full prescribing information for NEOSTIGMINE METHYLSULFATE INJECTION.NEOSTIGMINE METHYLSULFATE injection, for intravenous useInitial U.S. Approval: 1939
Approved
Approval ID
b0b509c3-8dc8-48cc-b7a8-16b93ad706c6
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Jan 1, 2024
Manufacturers
FDA
Fresenius Kabi USA, LLC
DUNS: 608775388
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Neostigmine Methylsulfate
PRODUCT DETAILS
NDC Product Code76045-383
Application NumberNDA203629
Marketing CategoryC73594
Route of AdministrationINTRAVENOUS
Effective DateMarch 30, 2022
Generic NameNeostigmine Methylsulfate
INGREDIENTS (6)
PHENOLInactive
Quantity: 4.5 mg in 1 mL
Code: 339NCG44TV
Classification: IACT
SODIUM ACETATEInactive
Quantity: 0.2 mg in 1 mL
Code: 4550K0SC9B
Classification: IACT
ACETIC ACIDInactive
Code: Q40Q9N063P
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
NEOSTIGMINE METHYLSULFATEActive
Quantity: 1 mg in 1 mL
Code: 98IMH7M386
Classification: ACTIB
Neostigmine Methylsulfate
PRODUCT DETAILS
NDC Product Code76045-214
Application NumberNDA203629
Marketing CategoryC73594
Route of AdministrationINTRAVENOUS
Effective DateMarch 30, 2022
Generic NameNeostigmine Methylsulfate
INGREDIENTS (6)
PHENOLInactive
Quantity: 4.5 mg in 1 mL
Code: 339NCG44TV
Classification: IACT
ACETIC ACIDInactive
Code: Q40Q9N063P
Classification: IACT
SODIUM ACETATEInactive
Quantity: 0.2 mg in 1 mL
Code: 4550K0SC9B
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
NEOSTIGMINE METHYLSULFATEActive
Quantity: 1 mg in 1 mL
Code: 98IMH7M386
Classification: ACTIB
WATERInactive
Code: 059QF0KO0R
Classification: IACT